Wall Street Experts
ver. ZuMIgo(08/25)
Heron Therapeutics, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 147
EBIT TTM (mln): -24
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
Rok finansowy |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
20 |
3 |
4 |
6 |
5 |
5 |
5 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
1 |
31 |
77 |
146 |
89 |
86 |
108 |
127 |
144 |
Przychód Δ r/r |
0.0% |
-83.5% |
30.3% |
32.5% |
-16.6% |
11.5% |
-0.2% |
-100.0% |
inf% |
-10.4% |
241.7% |
3.2% |
-50.3% |
-100.0% |
0.0% |
0.0% |
0.0% |
inf% |
2305.6% |
151.8% |
88.4% |
-39.3% |
-2.6% |
24.7% |
18.0% |
13.6% |
Marża brutto |
68.6% |
81.8% |
90.0% |
92.3% |
100.0% |
100.0% |
100.0% |
0.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
97.3% |
85.1% |
64.5% |
57.8% |
59.2% |
46.7% |
49.0% |
48.8% |
73.2% |
EBIT (mln) |
3 |
-4 |
-7 |
-5 |
-7 |
-9 |
-8 |
-19 |
-24 |
-23 |
-10 |
-10 |
-11 |
-24 |
-54 |
-75 |
-97 |
-171 |
-195 |
-184 |
-211 |
-228 |
-218 |
-175 |
-111 |
-12 |
EBIT Δ r/r |
0.0% |
-259.5% |
55.6% |
-28.0% |
37.1% |
40.9% |
-9.0% |
122.6% |
25.3% |
-0.8% |
-56.3% |
-3.0% |
11.4% |
115.4% |
128.5% |
36.9% |
30.0% |
76.3% |
13.8% |
-5.5% |
14.5% |
8.3% |
-4.5% |
-19.8% |
-36.7% |
-89.6% |
EBIT (%) |
13.2% |
-128.0% |
-152.8% |
-83.0% |
-136.4% |
-172.4% |
-157.2% |
0.0% |
-5736.2% |
-6353.7% |
-812.2% |
-763.6% |
-1712.4% |
0.0% |
0.0% |
0.0% |
0.0% |
-13363.2% |
-632.4% |
-237.4% |
-144.3% |
-257.4% |
-252.3% |
-162.2% |
-87.1% |
-8.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
3 |
4 |
3 |
1 |
2 |
2 |
2 |
4 |
6 |
EBITDA (mln) |
3 |
-4 |
-6 |
-4 |
-6 |
-9 |
-8 |
-42 |
-26 |
-23 |
-10 |
-12 |
-11 |
-24 |
-54 |
-75 |
-97 |
-171 |
-192 |
-184 |
-209 |
-228 |
-218 |
-175 |
-108 |
-5 |
EBITDA(%) |
15.7% |
-132.2% |
-145.5% |
-75.8% |
-130.1% |
-167.0% |
-149.0% |
0.0% |
-6274.5% |
-6223.8% |
-783.6% |
-956.7% |
-1684.7% |
0.0% |
0.0% |
0.0% |
0.0% |
-13363.2% |
-624.1% |
-237.4% |
-142.9% |
-257.4% |
-252.3% |
-162.2% |
-84.8% |
-3.5% |
Podatek (mln) |
0 |
-13 |
-4 |
-1 |
-2 |
-0 |
-0 |
0 |
0 |
-0 |
-0 |
-3 |
0 |
-1 |
-0 |
-1 |
-1 |
-1 |
4 |
8 |
0 |
-3 |
-3 |
-48 |
0 |
0 |
Zysk Netto (mln) |
2 |
9 |
-3 |
-4 |
-4 |
-9 |
-8 |
5 |
-20 |
-23 |
-10 |
-7 |
-12 |
-23 |
-55 |
-76 |
-98 |
-173 |
-197 |
-179 |
-205 |
-224 |
-218 |
-135 |
-111 |
-14 |
Zysk netto Δ r/r |
0.0% |
256.3% |
-129.4% |
50.3% |
15.5% |
111.3% |
-11.0% |
-164.1% |
-482.9% |
14.7% |
-56.6% |
-26.7% |
60.8% |
97.6% |
136.8% |
38.1% |
27.8% |
77.4% |
14.1% |
-9.4% |
14.5% |
9.6% |
-3.0% |
-38.2% |
-17.8% |
-87.7% |
Zysk netto (%) |
11.8% |
254.1% |
-57.3% |
-65.0% |
-90.0% |
-170.6% |
-152.3% |
0.0% |
-4893.9% |
-6266.9% |
-795.2% |
-564.6% |
-1828.8% |
0.0% |
0.0% |
0.0% |
0.0% |
-13537.4% |
-641.9% |
-230.8% |
-140.3% |
-253.2% |
-252.1% |
-124.9% |
-87.0% |
-9.4% |
EPS |
9.6 |
33.6 |
-9.92 |
-14.81 |
-16.98 |
-32.2 |
-26.15 |
66.4 |
-20.83 |
-15.01 |
-6.15 |
-3.7 |
-1.96 |
-1.91 |
-3.42 |
-2.87 |
-2.95 |
-4.57 |
-3.65 |
-2.44 |
-2.5 |
-2.47 |
-2.21 |
-1.24 |
-0.8 |
-0.0891 |
EPS (rozwodnione) |
9.6 |
33.6 |
-9.92 |
-14.81 |
-16.98 |
-32.2 |
-26.15 |
66.4 |
-20.83 |
-15.01 |
-6.15 |
-3.7 |
-1.96 |
-1.91 |
-3.42 |
-2.87 |
-2.95 |
-4.57 |
-3.65 |
-2.44 |
-2.5 |
-2.47 |
-2.21 |
-1.24 |
-0.8 |
-0.0891 |
Ilośc akcji (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
2 |
2 |
6 |
12 |
16 |
27 |
33 |
38 |
54 |
73 |
82 |
91 |
98 |
109 |
138 |
152 |
Ważona ilośc akcji (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
2 |
2 |
6 |
12 |
16 |
27 |
33 |
38 |
54 |
73 |
82 |
91 |
98 |
109 |
138 |
152 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |